The product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a condition known as fibrocystic breast condition (FBC).
OBGYN Dr Lisa Masterson said: "Fibrocystic breast condition is the generally accepted term to describe a common, benign condition that is associated with varying levels of monthly breast discomfort, including breast tenderness, aches, swelling, and heaviness.
"FBC affects an estimated 50% of women between the ages of 15-49, or over 35 million women in America, which is why I am thrilled there is now an option for my patients and the many women living with this condition to manage their discomfort."
FBC is thought to be caused by hormonal imbalances, which can cause breast tissue growth to exceed its natural cell turnover.
Breast tissue builds up month after month with each menstrual cycle, resulting in swollen, achy and tender breasts, and daily use of Violet iodine can help normalize these imbalances.
The drug address the underlying causes of fibrocystic breast condition, thereby alleviating symptoms that vary in severity from general soreness to clinically diagnosed FBC.
According to a clinical study, women taking a daily dose of either 3 or 6mg of iodine showed a decrease in monthly breast discomfort relative to women taking a daily dose of either a placebo or 1.5mg of iodine.